Related Experiment Video
Updated: Aug 22, 2026
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1
D Dimitroulopoulos1, S P Dourakis, D Xinopoulos
1Gastroenterology Unit, Saint Savvas Hospital, GR-152 34 Halandri, Athens, Greece. dimdim@otenet.gr
Abstract:
Immune thrombocytopenic purpura is an acquired disorder characterized by severe thrombocytopenia and caused by one or more antiplatelet autoantibodies. We present a case of a 20-year-old woman referred to our Unit for chronic hepatitis C virus (HCV) infection. At week 28 of treatment with interferon (alfacon-1), undetectable HCV RNA and transaminase levels within normal limits, the patient presented with immune thrombocytopenic purpura, which was successfully treated with immunoglobulin and methylprednisolone. Despite the high doses and long life of corticosteroid treatment HCV RNA remained undetectable.